Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 23, 2016 - Issue 1
Submit an article Journal homepage
632
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement

Xianghua HuangNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
,
Qingwen WangNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
,
Wencui ChenNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
,
Guisheng RenNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China
&
Zhihong LiuNational Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China;National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, ChinaCorrespondence[email protected]
Pages 51-57 | Received 19 May 2015, Accepted 04 Jan 2016, Published online: 10 Feb 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Liang Zhao, Guisheng Ren, Jinzhou Guo, Wencui Chen, Weiwei Xu & Xianghua Huang. (2022) The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement. Annals of Medicine 54:1, pages 1226-1232.
Read now
Xianghua Huang, Guisheng Ren, Wencui Chen, Jinzhou Guo, Liang Zhao, Caihong Zeng, Yongchun Ge & Zhihong Liu. (2021) The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients. Amyloid 28:2, pages 75-83.
Read now

Articles from other publishers (10)

Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kim, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, Chang-Ki Min, Fude Zhou, Zhen Cai, Xiaonong Chen, Shinsuke Iida, Nagaaki Katoh, Tomoaki Fujisaki, Ho-Jin Shin, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brenda Tromp, Brendan M. Weiss, Raymond L. Comenzo, Efstathios Kastritis & Jin Lu. (2023) Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA. Annals of Hematology 102:4, pages 863-876.
Crossref
Chengcheng Fu, Xiaohong Wang, Xian Cao, Lingjie Xu, Wang Liu, Jingnan Pi, Bin Wang & Wenming Chen. (2022) The Clinical Characteristics of Immunoglobulin Light Chain Amyloidosis in the Chinese Population: A Systematic Scoping Review. Hemato 4:1, pages 12-25.
Crossref
Charlene Lee, Annette Lam, Teresa Kangappaden, Pyper Olver, Sarah Kane, Diana Tran & Eric Ammann. (2022) Systematic literature review of evidence in amyloid light-chain amyloidosis. Journal of Comparative Effectiveness Research 11:6, pages 451-472.
Crossref
Joon Young Hur, Sang Eun Yoon, Darae Kim, Jin-oh Choi, Ju-Hong Min, Byung Jun Kim, Jung Sun Kim, Jung Eun Lee, Joon Young Choi, Eun-Seok Jeon, Seok Jin Kim & Kihyun Kim. (2021) Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis. BLOOD RESEARCH 56:4, pages 266-278.
Crossref
Baojian Liu, Yan Wang, Xiaoxuan Ning, Ming Bai, Di Wang, Jin Zhao, Meilan Zhou & Shiren Sun. (2021) A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosis. Current Problems in Cancer 45:2, pages 100669.
Crossref
Aaron M. Wolfson, Kevin S. Shah & Jignesh K. Patel. (2019) Amyloid and the Heart. Current Cardiology Reports 21:12.
Crossref
Baojian Liu, Ming Bai, Yan Wang, Di Wang, Jin Zhao, Lu Li, Ruijuan Dong & Shiren Sun. (2019) The efficacy and safety of bortezomib-based chemotherapy for immunoglobulin light chain amyloidosis: A systematic review and meta-analysis. European Journal of Internal Medicine 69, pages 32-41.
Crossref
Baojian Liu, Yan Wang, Ming Bai, Di Wang, Jin Zhao, Ming Zhang & Shiren Sun. (2019) Cyclophosphamide + Thalidomide + Dexamethasone Versus Melphalan + Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese Patients. Clinical Therapeutics 41:6, pages 1186-1198.
Crossref
Taxiarchis V. Kourelis, Samih H. Nasr, Angela Dispenzieri, Shaji K. Kumar, Morie A. Gertz, Fernando C. Fervenza, Francis K. Buadi, Martha Q. Lacy, Stephen B. Erickson, Fernando G. Cosio, Prashant Kapoor, John A. Lust, Suzanne R. Hayman, Vincent Rajkumar, Steven R. Zeldenrust, Stephen J. Russell, David Dingli, Yi Lin, Wilson Gonsalves, Elizabeth C. Lorenz, Ladan Zand, Robert A. Kyle & Nelson Leung. (2016) Outcomes of patients with renal monoclonal immunoglobulin deposition disease. American Journal of Hematology 91:11, pages 1123-1128.
Crossref
Xiang-Hua Huang & Zhi-Hong Liu. (2016) The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China. Kidney Diseases 2:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.